News & Press Releases Swedish

Scandinavian ChemTech får positivt utfall i FloridaWilds utvärdering av vetIQure[TM]

ChemoTechs Animal Care-division Vetiqure AB har meddelats att den utvärdering som FloridaWild Veterinary Hospital (”FloridaWild”) i Deland Florida gjort av bolagets vetIQure[TM] TSE-enhet avslutats med positivt utfall.

Read more

Kalqyl publicerar uppdragsanalys på Scandinavian ChemoTech

En uppdragsanalys på Scandinavian ChemoTech AB publicerades idag av Kalqyl AB och finns tillgänglig på deras hemsida.

Read more

Scandinavian ChemoTech meddelar att TSE™-behandling har inletts vid Ulis Medical Center i Ukraina

Efter att ha avslutat utbildningen av läkare, sjuksköterskor och stödpersonal vid Ulis Medical Center i Ukraina förra veckan startade programmet idag och den första patienten behandlades.

Read more

News & Press Releases English

Kalqyl publish initial take analysis on Scandinavian ChemoTech

A commissioned research analysis was published today by Kalqyl AB and is accessible on their website.

Read more

Scandinavian ChemoTech announces that TSE™ therapy has been initiated at Ulis Medical Centre in Ukraine

After concluding the training of doctors, nurses and support staff at Ulis Medical Centre in Ukraine last week, the program started today and the first patient was treated.

Read more

Scandinavian ChemoTech holds the first training session at Ulis Medical Centre in Ukraine

We are pleased to announce that doctors and nurses at the Ulis Medical Centre (Ulis MC) in Zaporizhia, Ukraine attended their first training session with IQwave™ 3.0 CE and TSE yesterday.

Read more

ChemoTech Videos

2022

SWECARE at EXPO 2020 DUBAI: "Closing Ceremony"

A conversation with Småbolagspodden

(Audio in Swedish)

I det senaste avsnittet av Småbolagspodden berättar Scandinavian ChemoTechs vd Mohan Frick om hur bolagets unika metod för cancerbehandling, via så kallad tumörspecifik elektroporation, ska hjälpa människor och djur världen över.

Lyssna på hela avsnittet här:
52. ChemoTech – Vill vara en kraft för skonsammare cancervård

2021

Presentation of Q3 - Analysera med oss November 2021 (Swedish)

ChemoTech presents for its upcoming Annual General meeting 24 May 2021. Spoken language is Swedish but the presentation is in English.

Innovative TSE technology increases the local effect of chemotherapy (Swedish)

ChemoTech answers questions from the shareholders; Part 1 (Swedish)

CEO Mohan Frick presenting at Erik Penser Bank Bolagsdag (Swedish)

Erik Penser Bank interview with CEO Mohan Frick (Swedish) 8 January 2021

Videos from 2020

Company Presentation of the Q3 report (Swedish) 11th of November 2020

Company Presentation (Swedish) 27th of October 2020

Videos from 2019

Share Day in Gothenburg, November 4 2019 (Swedish)

Videos from 2018

Share analysis ChemoTech Q2 2018 (Swedish)

Share Day in Malmö on May 22, 2018 (Swedish)

Our foundation

Our profound knowledge in electroporation forms the starting point for the company’s existing product and R&D projects: The IQwave™ specially designed for our TSE™ – Tumour Specific Electroporation technology which treats a range of various tumours.

Our research focus

Our aim is to document the effects of elctrochemotherapy for pain management for cancer patients, an area with significant unmet medical need.